Aquestive Therapeutics Inc (AQST) — Strategic Asset Allocation Index
Aquestive Therapeutics Inc (AQST) has a Strategic Asset Allocation Index of 121.1% as of December 2018. Strategic assets (PP&E of $12.21 Million plus long-term investments of $-) total $12.21 Million, measured against net assets of $10.08 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Aquestive Therapeutics Inc Strategic Asset Allocation Index (2005–2018)
This chart shows how Aquestive Therapeutics Inc's Strategic Asset Allocation Index has evolved across 3 annual periods from 2005 to 2018. As of December 2018, the index stands at 121.1%, representing strategic assets of $12.21 Million against net assets of $10.08 Million USD. Explore cash flow conversion of Aquestive Therapeutics Inc to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Aquestive Therapeutics Inc (2005–2018)
The table below presents the year-by-year Strategic Asset Allocation Index for Aquestive Therapeutics Inc from 2005 to 2018, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Aquestive Therapeutics Inc market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2018 | 121.1% | $12.21 Million | $12.21 Million | $- | $10.08 Million | ▲ +87.2 pp |
| 2006 | 33.9% | $8.56 Million | $8.56 Million | $- | $25.26 Million | ▼ -129.3 pp |
| 2005 | 163.2% | $7.61 Million | $7.61 Million | $- | $4.67 Million | — |